Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v9-FR
Language French French
Date Updated 2018-08-31 2018-08-24
Drug Identification Number 02221829 02221829
Brand name ALTACE ALTACE
Common or Proper name ALTACE ALTACE
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients RAMIPRIL RAMIPRIL
Strength(s) 1.25MG 1.25MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 30 caps 30 caps
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-08-08 2018-08-08
Estimated end date 2018-08-28
Actual end date 2018-08-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments